AAAAAA

   
Results: 1-20 |
Results: 20
Screening for subclinical nephropathy in relatives of dialysis patients
Authors: Satko, SG Freedman, BI
Citation: Sg. Satko et Bi. Freedman, Screening for subclinical nephropathy in relatives of dialysis patients, SEMIN DIAL, 14(5), 2001, pp. 311-313
A high-resolution 6.0-megabase transcript map of the type 2 diabetes susceptibility region on human chromosome 20
Authors: Fossey, SC Mychaleckyj, JC Pendleton, JK Snyder, JR Bensen, JT Hirakawa, S Rich, SS Freedman, BI Bowden, DW
Citation: Sc. Fossey et al., A high-resolution 6.0-megabase transcript map of the type 2 diabetes susceptibility region on human chromosome 20, GENOMICS, 76(1-3), 2001, pp. 45-57
Non-diabetic nodular glomerulosclerosis associated with p-ANCA seropositivity: a case report and review of the literature
Authors: Satko, SG Freedman, BI Iskandar, SS
Citation: Sg. Satko et al., Non-diabetic nodular glomerulosclerosis associated with p-ANCA seropositivity: a case report and review of the literature, CLIN NEPHR, 56(1), 2001, pp. 69-74
Family history of end-stage renal disease does not predict dialytic survival
Authors: Freedman, BI Soucie, JM Kenderes, B Krisher, J Garrett, LE Caruana, RJ McClellan, WM
Citation: Bi. Freedman et al., Family history of end-stage renal disease does not predict dialytic survival, AM J KIDNEY, 38(3), 2001, pp. 547-552
Familial aggregation of coronary artery calcium in families with type 2 diabetes
Authors: Wagenknecht, LE Bowden, DW Carr, JJ Langefeld, CD Freedman, BI Rich, SS
Citation: Le. Wagenknecht et al., Familial aggregation of coronary artery calcium in families with type 2 diabetes, DIABETES, 50(4), 2001, pp. 861-866
Genes and renal disease
Authors: Freedman, BI Satko, SG
Citation: Bi. Freedman et Sg. Satko, Genes and renal disease, CURR OP NEP, 9(3), 2000, pp. 273-277
Identification and characterization of PRKCBP1, a candidate RACK-like protein
Authors: Fossey, SC Kuroda, S Price, JA Pendleton, JK Freedman, BI Bowden, DW
Citation: Sc. Fossey et al., Identification and characterization of PRKCBP1, a candidate RACK-like protein, MAMM GENOME, 11(10), 2000, pp. 919-925
Genetic analysis of nitric oxide and endothelin in end-stage renal disease
Authors: Freedman, BI Yu, HR Anderson, PJ Roh, BH Rich, SS Bowden, DW
Citation: Bi. Freedman et al., Genetic analysis of nitric oxide and endothelin in end-stage renal disease, NEPH DIAL T, 15(11), 2000, pp. 1794-1800
Genomic structure of the human plasma prekallikrein gene, identification of allelic variants, and analysis in end-stage renal disease
Authors: Yu, HR Anderson, PJ Freedman, BI Rich, SS Bowden, DW
Citation: Hr. Yu et al., Genomic structure of the human plasma prekallikrein gene, identification of allelic variants, and analysis in end-stage renal disease, GENOMICS, 69(2), 2000, pp. 225-234
Management of ischemic nephropathy: Dialysis-free survival after surgical repair
Authors: Hansen, KJ Cherr, GS Craven, TE Motew, SJ Travis, JA Wong, JM Levy, PJ Freedman, BI Ligush, J Dean, RH
Citation: Kj. Hansen et al., Management of ischemic nephropathy: Dialysis-free survival after surgical repair, J VASC SURG, 32(3), 2000, pp. 472-481
Racial variation in autosomal dominant polycystic kidney disease
Authors: Freedman, BI Soucie, JM Chapman, A Krisher, J McClellan, WM
Citation: Bi. Freedman et al., Racial variation in autosomal dominant polycystic kidney disease, AM J KIDNEY, 35(1), 2000, pp. 35-39
Human Na plus /H plus exchanger genes - Identification of polymorphisms byradiation hybrid mapping and analysis of linkage in end-stage renal disease
Authors: Yu, HR Freedman, BI Rich, SS Bowden, DW
Citation: Hr. Yu et al., Human Na plus /H plus exchanger genes - Identification of polymorphisms byradiation hybrid mapping and analysis of linkage in end-stage renal disease, HYPERTENSIO, 35(1), 2000, pp. 135-143
Analysis of the HNF4 alpha gene in Caucasian Type II diabetic nephropathicpatients
Authors: Price, JA Fossey, SC Sale, MM Brewer, CS Freedman, BI Wuerth, JP Bowden, DW
Citation: Ja. Price et al., Analysis of the HNF4 alpha gene in Caucasian Type II diabetic nephropathicpatients, DIABETOLOG, 43(3), 2000, pp. 364-372
Worldwide ethnic distribution of the G protein beta 3 subunit 825T allele and its association with obesity in Caucasian, Chinese, and Black African individuals
Authors: Siffert, W Forster, P Jockel, KH Mvere, DA Brinkmann, B Naber, C Crookes, R Heyns, ADP Epplen, JT Fridey, J Freedman, BI Muller, N Stolke, D Sharma, AM Al Moutaery, K Grosse-Wilde, H Buerbaum, B Ehrlich, T Ahmad, HR Horsthemke, B Du Toit, ED Tiilikainen, A Ge, JB Wang, YL Yang, DL Husing, J Rosskopf, D
Citation: W. Siffert et al., Worldwide ethnic distribution of the G protein beta 3 subunit 825T allele and its association with obesity in Caucasian, Chinese, and Black African individuals, J AM S NEPH, 10(9), 1999, pp. 1921-1930
Familial aggregation of end-stage renal failure: aetiological implications
Authors: Freedman, BI
Citation: Bi. Freedman, Familial aggregation of end-stage renal failure: aetiological implications, NEPH DIAL T, 14(2), 1999, pp. 295-297
Candidate gene analysis in African Americans with renal failure
Authors: Buckalew, VM Freedman, BI
Citation: Vm. Buckalew et Bi. Freedman, Candidate gene analysis in African Americans with renal failure, RENAL FAIL, 21(3-4), 1999, pp. 403-407
Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy
Authors: Freedman, BI Soucie, JM Stone, SM Pegram, S
Citation: Bi. Freedman et al., Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy, AM J KIDNEY, 34(2), 1999, pp. 254-258
Evaluation of markers on human chromosome 10, including the homologue of the rodent Rf-1 gene, for linkage to ESRD in black patients
Authors: Yu, HR Sale, M Rich, SS Spray, BJ Roh, BH Bowden, DW Freedman, BI
Citation: Hr. Yu et al., Evaluation of markers on human chromosome 10, including the homologue of the rodent Rf-1 gene, for linkage to ESRD in black patients, AM J KIDNEY, 33(2), 1999, pp. 294-300
Design and baseline characteristics for the aminoguanidine clinical trial in overt type 2 diabetic nephropathy (ACTION II)
Authors: Freedman, BI Wuerth, JP Cartwright, K Bain, RP Dippe, S Hershon, K Mooradian, AD Spinowitz, BS
Citation: Bi. Freedman et al., Design and baseline characteristics for the aminoguanidine clinical trial in overt type 2 diabetic nephropathy (ACTION II), CONTR CL TR, 20(5), 1999, pp. 493-510
Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes
Authors: Gonzalez, E Bamshad, M Sato, N Mummidi, S Dhanda, R Catano, G Cabrera, S McBride, M Cao, XH Merrill, G O'Connell, P Bowden, DW Freedman, BI Anderson, SA Walter, EA Evans, JS Stephan, KT Clark, RA Tyagi, S Ahuja, SS Dolan, MJ Ahuja, SK
Citation: E. Gonzalez et al., Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes, P NAS US, 96(21), 1999, pp. 12004-12009
Risultati: 1-20 |